학술논문
The safety and efficacy of relebactam/imipenem/cilastatin in Japanese patients with complicated intra-abdominal infection or complicated urinary tract infection: A multicenter, open-label, noncomparative phase 3 study
Document Type
Article
Author
Source
In Journal of Infection and Chemotherapy February 2021 27(2):262-270
Subject
Language
ISSN
1341-321X